BRIEF published on 05/21/2026 at 17:50, 1 day 6 hours ago Median Technologies publie les documents de l'assemblée générale des actionnaires Droit De Vote Euronext Croissance Assemblée Générale Des Actionnaires Technologies Médianes Disponibilité Des Documents
BRIEF published on 05/21/2026 at 17:50, 1 day 6 hours ago Median Technologies Publishes Shareholder Meeting Documents Voting Rights Shareholders’ Meeting Euronext Growth Median Technologies Documents Availability
PRESS RELEASE published on 05/21/2026 at 17:45, 1 day 6 hours ago Terms of availability of the information and the report on corporate governance Median Technologies releases preparatory documents for the Annual Shareholders’ Meeting on June 10, 2026. Shareholders can access documents on the company's website Shareholders General Meeting Annual Shareholders’ Meeting Preparatory Documents Median Technologies
BRIEF published on 03/30/2026 at 15:19, 1 month 23 days ago Median Technologies obtient la certification ISO 13485:2016 ISO 13485:2016 Normes Réglementaires Logiciel Basé Sur L'IA Solutions En Oncologie Eyonis®
BRIEF published on 03/30/2026 at 15:19, 1 month 23 days ago Median Technologies Achieves ISO 13485:2016 Certification ISO 13485:2016 Regulatory Standards Oncology Solutions Eyonis® AI-based SaMD
PRESS RELEASE published on 03/30/2026 at 15:14, 1 month 23 days ago Inside Information / Other news releases Median Technologies achieves ISO 13485:2016 certification for eyonis® Medical Device Quality Management System, reinforcing commitment to safe and reliable oncology solutions Median Technologies AI-based Software Oncology Solutions ISO 13485:2016 Certification Eyonis Medical Device
BRIEF published on 02/12/2026 at 22:10, 3 months 10 days ago Median Technologies and Tempus Partner to Expand Lung Cancer Screening in the U.S. FDA Clearance Median Technologies Lung Cancer Screening Eyonis® LCS Tempus AI
BRIEF published on 02/12/2026 at 22:10, 3 months 10 days ago Median Technologies et Tempus s'associent pour étendre le dépistage du cancer du poumon aux États-Unis. Autorisation De La FDA Technologies Médianes Dépistage Du Cancer Du Poumon Eyonis® LCS Tempus IA
PRESS RELEASE published on 02/12/2026 at 22:05, 3 months 10 days ago Informations privilégiées / Autres communiqués Median Technologies collabore avec Tempus pour distribuer le logiciel eyonis® LCS aux États-Unis, suite à l'obtention de l'autorisation FDA 510(k) pour le dépistage du cancer du poumon via Tempus Pixel Median Technologies Eyonis® LCS Tempus FDA 510(k) Dépistage Cancer
PRESS RELEASE published on 02/12/2026 at 22:05, 3 months 10 days ago Inside Information / Other news releases Median Technologies collaborates with Tempus to expand access to eyonis® LCS Software as a Medical Device in the US following FDA 510(k) clearance, enhancing lung cancer screening with AI tools FDA Clearance AI Tools Median Technologies Eyonis® LCS Tempus
Published on 05/23/2026 at 00:00, just now Redwood AI Announces Collaboration with Resilience Biosciences Inc. to Advance AI-Assisted Small-Molecule Drug Development
Published on 05/22/2026 at 14:04, 9 hours 56 minutes ago Wi2Wi Corporation Announces First Quarter 2026 Financial Results (Unaudited)
Published on 05/22/2026 at 14:00, 10 hours ago Imagine Health Achieves Teaching Facility Status Through University of Calgary Faculty Partnership
Published on 05/22/2026 at 22:05, 1 hour 55 minutes ago Abivax présente ses résultats financiers du T1 2026 et les données à trois ans de l’étude 108, un essai d’extension ouvert de phase 2a/2b évaluant l’obéfazimod après réduction de dose dans la RCH
Published on 05/22/2026 at 22:05, 1 hour 55 minutes ago Abivax Presents Q1 2026 Financial Results and Reports Three-Year Interim Data from Study 108, a Phase 2a/2b Open-Label Extension Trial of Obefazimod Following Dose De-Escalation in Patients with UC
Published on 05/22/2026 at 19:51, 4 hours 9 minutes ago Turkiye Garanti Bankasi A.S.: Brokerage Houses Warrants Redemption Prices
Published on 05/22/2026 at 18:33, 5 hours 27 minutes ago Update on Coupon payment due on 23 May 2026 and Preparation of the Green Bond Restructuring
Published on 05/22/2026 at 18:30, 5 hours 30 minutes ago Annual General Meeting of Curatis Holding AG approved all proposals of the Board of Directors
Published on 05/22/2026 at 19:35, 4 hours 25 minutes ago PROJET D'EVOLUTION DE SA GOUVERNANCE ET LA NOMINATION D'UN PRESIDENT DU DIRECTOIRE PAR INTERIM
Published on 05/22/2026 at 18:05, 5 hours 55 minutes ago Déclaration hebdomadaire d'opérations effectuées du 18 au 22 mai 2026
Published on 05/22/2026 at 18:05, 5 hours 55 minutes ago Disclosure of transactions in own shares from May 18 to May 22, 2026
Published on 05/22/2026 at 12:52, 11 hours 7 minutes ago Communiqué du Conseil d’administration – Assemblée Générale du 22 mai 2026
Published on 05/22/2026 at 12:52, 11 hours 7 minutes ago Release from the Board of Directors - Shareholders’ Meeting of May 22, 2026
